Substances that can change alternative splice-site selection

Biochemical Society Transactions

Volumn 36, Issue 3, 2008, Pages 483-490

  Sumanasekera, Chiranthani ^a   Watt, David S ^a   Stamm, Stefan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alternative pre mRNA splicing; Exon; Histone deacetylase inhibitor; Phosphorylation; Serine arginine rich protein; Splice site selection

Indexed keywords

ALCOHOL; CHEMICAL COMPOUND; CYCLIC AMP; DIMETHYL SULFOXIDE; EPIGALLOCATECHIN GALLATE; ETOPOSIDE; HISTONE DEACETYLASE INHIBITOR; HYDROXYUREA; ION CHANNEL; KINETIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOTRANSFERASE INHIBITOR; RESVERATROL; STEROID HORMONE;

ALTERNATIVE RNA SPLICING; CONFERENCE PAPER; EUKARYOTE; EXON; GENE EXPRESSION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ALTERNATIVE SPLICING; ANIMALS; HUMANS; RNA SPLICE SITES;

EUKARYOTA;

EID: 45249091505     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360483     Document Type: Conference Paper

References (61)

1. Kampa, D., Cheng, J., Kapranov, P., Yamanaka, M., Brubaker, S., Cawley, S., Drenkow, J., Piccolboni, A., Bekiranov, S., Helt, G. et al. (2004) Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res. 14, 331-342
2. Johnson, J.M., Castle, J., Garrett-Engele, P., Kan, Z., Loerch, P.M., Armour, C.D., Santos, R., Schadt, E.E., Stoughton, R. and Shoemaker, D.D. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302, 2141-2144
3. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T.A. and Soreq, H. (2005) Function of alternative splicing. Gene 344, 1-20
4. Forch, P. and Valcarcel, J. (2003) Splicing regulation in Drosophila sex determination. Prog. Mol. Subcell. Biol. 31, 127-151
5. Wu, J.Y., Tang, H. and Havlioglu, N. (2003) Alternative pre-mRNA splicing and regulation of programmed cell death. Prog. Mol. Subcell. Biol. 31, 153-185
6. Jurica, M.S. and Moore, M.J. (2003) Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell 12, 5-14
7. Smith, C.W. and Valcarcel, J. (2000) Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25, 381-388
8. Stamm, S. (2002) Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum. Mol. Genet. 11, 2409-2416
9. Shin, C. and Manley, J.L. (2004) Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell Biol. 5, 727-738
10. Blaustein, M., Pelisch, F. and Srebrow, A. (2007) Signals, pathways and splicing regulation. Int. J. Biochem. Cell Biol. 39, 2031-2048
11. Daoud, R., Da Penha Berzaghi, M., Siedler, F., Hubener, M. and Stamm, S. (1999) Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci. 11, 788-802
12. Stamm, S. (2008) Regulation of alternative splicing by reversible phosphorylation. J. Biol. Chem. 283, 1223-1227
13. Soulard, M., Della Valle, V., Siomi, M.C., Pinol-Roma, S., Codogno, P., Bauvy, C., Bellini, M., Lacroix, J.C., Monod, G., Dreyfuss, G. and Larsen, C.-J. (1993) hnRNP G: seguence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res. 21, 4210-4217
14. Babic, I., Jakymiw, A. and Fujita, D.J. (2004) The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity. Oncogene 23, 3781-3789
15. Rho, J., Choi, S., Jung, C.R. and Im, D.S. (2007) Arginine methylation of Sam68 and SLM proteins negatively regulates their poly(U) RNA binding activity. Arch. Biochem. Biophys. 466, 49-57
16. Faustino, N.A. and Cooper, T.A. (2003) Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437
17. Stoilov, P., Meshorer, E., Gencheva, M., Glick, D., Soreg, H. and Stamm, S. (2002) Defects in pre-mRNA processing as causes of and predisposition to diseases. DNA Cell Biol. 21, 803-818
18. Venables, J.P. (2006) Unbalanced alternative splicing and its significance in cancer. BioEssays 28, 378-386
19. Hagiwara, M. (2005) Alternative splicing: a new drug target of the post-genome era. Biochim. Biophys. Acta 1754, 324-331
20. Bracco, L. and Kearsey, J. (2003) The relevance of alternative RNA splicing to pharmacogenomics. Trends Biotechnol. 21, 346-353
21. Hernandez, F., Perez, M., Lucas, J.J., Mata, A.M., Bhat, R. and Avila, J. (2004) Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35: implications for Alzheimer's disease. J. Biol. Chem. 279, 3801-3806
22. Brichta, L., Hofmann, Y., Hahnen, E., Siebzehnrubl, F.A., Raschke, H., Blumcke, I., Eyupoglu, I.Y. and Wirth, B. (2003) Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum. Mol. Genet. 12, 2481-2489
23. Aartsma-Rus, A. and van Ommen, G.J. (2007) Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. RNA 13, 1609-1624
24. Eckstein, F. (2007) The versatility of oligonucleotides as potential therapeutics. Expert Opin. Biol. Ther. 7, 1021-1034
25. Wirth, B., Brichta, L. and Hahnen, E. (2006) Spinal muscular atrophy: from gene to therapy. Semin. Pediatr. Neurol. 13, 121-131
26. Chang, J.G., Hsieh-Li, H.M., Jong, Y.J., Wang, N.M., Tsai, C.H. and Li, H. (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. U.S.A. 98, 9808-9813
27. Rossi, F., Labourier, E., Forne, T., Divita, G., Derancourt, J., Riou, J.F., Antione, E., Cathela, G., Brunel, C. and Tazi, J. (1996) Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 381, 80-82
28. Tazi, J., Rossi, F., Labourier, E., Gallouzi, I., Brunel, C. and Antoine, E. (1997) DNA topoisomerase L customs officer at the border between DNA and RNA worlds? J. Mol. Med. 75, 786-800
29. Muraki, M., Ohkawara, B., Hosoya, T., Onogi, H., Koizumi, J., Koizumi, T., Sumi, K., Yomoda, J.I., Murray, M.V., Kimura, H. et al. (2004) Manipulation of alternative splicing by a newly developed inhibitor of Clks. J. Biol. Chem. 279, 24246-24254
30. Fukuhara, T., Hosoya, T., Shimizu, S., Sumi, K., Oshiro, T., Yoshinaka, Y., Suzuki, M., Yamamoto, N., Herzenberg, L.A. and Hagiwara, M. (2006) Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc. Natl. Acad. Sci. U.S.A. 103, 11329-11333
31. Gasparini, L., Terni, B. and Spillantini, M.G. (2007) Frontotemporal dementia with tau pathology. Neurodegener. Dis. 4, 236-253
32. Novoyatleva, T., Heinrich, B., Tang, Y., Benderska, N., Butchbach, M.E., Lorson, C.L., Lorson, M.A., Ben-Dov, C., Fehlbaum, P., Bracco, L. et al. (2008) Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Hum. Mol. Genet. 17, 52-70
33. Chalfant, C.E., Rathman, K., Pinkerman, R.L., Wood, R.E., Obeid, L.M., Ogretmen, B. and Hannun, Y.A. (2002) De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells: dependence on protein phosphatase-1. J. Biol. Chem. 277, 12587-12595
34. Angelozzi, C., Borgo, F., Tiziano, F.D., Martella, A., Neri, G. and Brahe, C. (2007) Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. J. Med. Genet. 45, 29-31
35. Lunn, M.R., Root, D.E., Martino, A.M., Flaherty, S.P., Kelley, B.P., Coovert, D.D., Burghes, A.H., Man, N.T., Morris, G.E. and Zhou, J. et al. (2004) Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem. Biol. 11, 1489-1493
36. Auboeuf, D., Honig, A., Berget, S.M. and O'Malley, B.W. (2002) Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298, 416-419
37. Dowhan, D.H., Hong, E.P., Auboeuf, D., Dennis, A.P., Wilson, M.M., Berget, S.M. and O'Malley, B.W. (2005) Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERα and CAPERβ. Mol. Cell 17, 429-439
38. Soret, J., Bakkour, N., Maire, S., Durand, S., Zekri, L., Gabut, M., Fic, W., Divita, G., Rivalle, C., Dauzonne, D. et al. (2005) Selective modification of alternative splicing by indole derivatives that target SR protein splicing factors. Proc. Natl. Acad. Sci. U.S.A. 102, 8764-8769
39. Bakkour, N., Lin, Y.L., Maire, S., Ayadi, L., Mahuteau-Betzer, F., Nguyen, C.H., Mettling, C., Portales, P., Grierson, D., Chabot, B. et al. (2007) Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance. PLoS Pathog. 3, 1530-1539
40. Xie, J. and Black, D.L. (2001) A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels. Nature 410, 936-939
41. Andreassi, C., Angelozzi, C., Tiziano, F.D., Vitali, T., De Vincenzi, E., Boninsegna, A., Villanova, M., Bertini, E., Pini, A., Neri, G. and Brahe, C. (2004) Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscle atrophy. Eur. J. Hum. Genet. 12, 59-65
42. Riessland, M., Brichta, L., Hahnen, E. and Wirth, B. (2006) The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SM2 RNA/protein levels in spinal muscular atrophy cells. Hum. Genet. 120, 101-110
43. Hahnen, E., Eyupoglu, I.Y., Brichta, L., Haastert, K., Trankle, C., Siebzehnrubl, F.A., Riessland, M., Holker, I., Claus, P., Romstock, J. et al. (2006) In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J. Neurochem. 98, 193-202
44. Andreassi, C., Jarecki, J., Zhou, J., Coovert, D.D., Monani, U.R., Chen, X., Witney, M., Pollok, B., Zhang, M., Androphy, E. and Burghes, A.H. (2001) Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum. MoI. Genet. 10, 2841-2849
45. Solier, S., Lansiaux, A., Logette, E., Wu, J., Soret, J., Tazi, J., Bailly, C., Desoche, L., Solary, E. and Corcos, L. (2004) Topoisomerase I and Il inhibitors control caspase-2 pre-messenger RNA splicing in human cells. Mol. Cancer Res. 2, 53-61
46. Pilch, B., Allemand, E., Facompre, M., Bailly, C., Riou, J.F., Soret, J. and Tazi, J. (2001) Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 61, 6876-6884
47. Ting, C.Y., Hsu, C.T., Hsu, H.T., Su, J.S., Chen, T.Y., Tarn, W.Y., Kuo, Y.H. Whang-Peng, J., Liu, LF. and Hwang, J. (2003) Isodiospyrin as a novel human DNA topoisomerase I inhibitor. Biochem. Pharmacol. 66, 1981-1991
48. Bhat, R., Xue, Y., Berg, S., Hellberg, S., Ormo, M., Nilsson, Y., Radesater, A.C., Jerning, E., Markgren, P.O., Borgegard, T. et al. (2003) Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J. Biol. Chem. 278, 45937-45945
49. Zhang, M.L., Lorson, C.L., Androphy, E.J. and Zhou, J. (2001) An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene. Ther. 8, 1532-1538
50. Kosaki, A. and Webster, N.J. (1993) Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J. Biol. Chem. 268, 21990-21996
51. Lai, G.J. and McCobb, O.D. (2002) Opposing actions of adrenal androgens and glucocorticoids on alternative splicing of Slo potassium channels in bovine chromaffin cells. Proc. Natl. Acad. Sci. U.S.A. 99, 7722-7727
52. Yuo, C.Y., Lin, H.H., Chang, Y.S., Yang, W.K. and Chang, J.G. (2008) 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Ann. Neurol. 63, 26-34
53. Sgambato, V., Minassian, R., Nairn, A.C. and Hyman, S.E. (2003) Regulation of ania-6 splice variants by distinct signaling pathways in striatal neurons. J. Neurochem. 86, 153-164
54. Meshul, C.K., Bunker, G.L., Mason, J.N., Allen, C and Janowsky, A. (1996) Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. J. Neurochem. 67, 1965-1973
55. Grzeschik, S.M., Ganta, M., Prior, T.W., Heavlin, W.D. and Wang, C.H. (2005) Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann. Neurol. 58, 194-202
56. Walter, H.J., McMahon, T., Dadgar, J., Wang, D. and Messing, R.O. (2000) Ethanol regulates calcium channel subunits by protein kinase Cδ-dependent and -independent mechanisms. J. Biol. Chem. 275, 25717-25722
57. Bolduc, L., Labrecque, B., Cordeau, M., Blanchette, M. and Chabot, B. (2001) Dimethyl sulfoxide affects the selection of splice sites. J. Biol. Chem. 276, 17597-17602
58. Slaugenhaupt, S.A., Mull, J., Leyne, M., Cuajungco, M.P., Gill, S.P., Hims, M.M., Quintero, F., Axelrod, F.B. and Gusella, J.F. (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum. Mol. Genet. 13, 429-436
59. Montecucco, A. and Biamonti, G. (2007) Cellular response to etoposide treatment. Cancer Lett. 252, 9-18
60. Sakla, M.S. and Lorson, C.L. (2008) Induction of full-length survival motor neuron by polyphenol botanical compounds. Hum. Genet. 122, 635-643
61. Anderson, S.L., Qiu, J. and Rubin, B.Y. (2003) EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochem. Biophys. Res. Commun. 310, 627-633